Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diabetes, Gestational | 58 | 2024 | 1184 | 8.610 |
Why?
|
DNA Methylation | 82 | 2024 | 4286 | 6.640 |
Why?
|
Fetal Blood | 53 | 2023 | 1318 | 5.640 |
Why?
|
Insulin Resistance | 38 | 2024 | 3864 | 4.230 |
Why?
|
Adiposity | 30 | 2023 | 1807 | 4.110 |
Why?
|
Blood Glucose | 50 | 2024 | 6256 | 3.840 |
Why?
|
Placenta | 30 | 2024 | 1698 | 3.770 |
Why?
|
Prenatal Exposure Delayed Effects | 35 | 2023 | 2408 | 3.220 |
Why?
|
Pregnancy | 171 | 2024 | 29144 | 3.080 |
Why?
|
Hyperglycemia | 13 | 2024 | 1373 | 2.930 |
Why?
|
Adiponectin | 18 | 2021 | 1100 | 2.890 |
Why?
|
Fluorocarbons | 14 | 2023 | 452 | 2.810 |
Why?
|
Weight Gain | 17 | 2024 | 2292 | 2.740 |
Why?
|
Glucose Tolerance Test | 30 | 2024 | 1150 | 2.610 |
Why?
|
Birth Weight | 31 | 2023 | 2069 | 2.600 |
Why?
|
Leptin | 14 | 2021 | 1599 | 2.500 |
Why?
|
Epigenesis, Genetic | 54 | 2024 | 3647 | 2.340 |
Why?
|
Body Mass Index | 73 | 2024 | 12720 | 2.240 |
Why?
|
Diabetes Mellitus, Type 2 | 54 | 2024 | 11725 | 2.160 |
Why?
|
Alkanesulfonic Acids | 9 | 2023 | 180 | 1.930 |
Why?
|
Environmental Pollutants | 16 | 2023 | 1179 | 1.850 |
Why?
|
Pregnancy Trimester, Second | 10 | 2021 | 732 | 1.770 |
Why?
|
American Heart Association | 7 | 2023 | 1056 | 1.760 |
Why?
|
CpG Islands | 22 | 2022 | 1172 | 1.570 |
Why?
|
Fetal Development | 15 | 2023 | 767 | 1.530 |
Why?
|
Insulin | 27 | 2024 | 6580 | 1.520 |
Why?
|
Pregnancy Complications | 17 | 2021 | 2861 | 1.470 |
Why?
|
Genome-Wide Association Study | 48 | 2024 | 12261 | 1.440 |
Why?
|
Infant, Newborn | 80 | 2024 | 25625 | 1.400 |
Why?
|
Obesity | 40 | 2024 | 12745 | 1.390 |
Why?
|
Epigenomics | 15 | 2023 | 903 | 1.280 |
Why?
|
Life Style | 16 | 2023 | 3835 | 1.270 |
Why?
|
Female | 258 | 2024 | 380194 | 1.250 |
Why?
|
Absorptiometry, Photon | 4 | 2022 | 1725 | 1.220 |
Why?
|
Prospective Studies | 71 | 2024 | 53288 | 1.200 |
Why?
|
Hypertension, Pregnancy-Induced | 10 | 2024 | 489 | 1.130 |
Why?
|
Humans | 309 | 2024 | 744343 | 0.990 |
Why?
|
Pregnant Women | 2 | 2021 | 568 | 0.960 |
Why?
|
Obesity, Abdominal | 3 | 2022 | 361 | 0.920 |
Why?
|
Infant Nutritional Physiological Phenomena | 3 | 2023 | 347 | 0.920 |
Why?
|
Adult | 133 | 2024 | 214055 | 0.910 |
Why?
|
Child Development | 9 | 2023 | 2223 | 0.890 |
Why?
|
Overweight | 12 | 2022 | 2371 | 0.890 |
Why?
|
Tumor Necrosis Factor-alpha | 6 | 2021 | 4420 | 0.890 |
Why?
|
Polymorphism, Single Nucleotide | 32 | 2022 | 15519 | 0.870 |
Why?
|
Parturition | 4 | 2023 | 441 | 0.870 |
Why?
|
Child | 89 | 2024 | 77709 | 0.860 |
Why?
|
Genetic Predisposition to Disease | 23 | 2024 | 17446 | 0.840 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 2 | 2018 | 357 | 0.840 |
Why?
|
Pregnancy Trimester, First | 12 | 2022 | 853 | 0.820 |
Why?
|
Pre-Eclampsia | 7 | 2024 | 1200 | 0.820 |
Why?
|
Mothers | 15 | 2023 | 2165 | 0.810 |
Why?
|
Glucose Intolerance | 10 | 2023 | 577 | 0.800 |
Why?
|
Resistin | 4 | 2010 | 170 | 0.790 |
Why?
|
Child, Preschool | 52 | 2024 | 41006 | 0.750 |
Why?
|
Maternal-Fetal Exchange | 5 | 2019 | 456 | 0.750 |
Why?
|
Body Weight | 10 | 2021 | 4669 | 0.730 |
Why?
|
Subcutaneous Fat, Abdominal | 1 | 2020 | 93 | 0.710 |
Why?
|
Genotype | 17 | 2023 | 12951 | 0.700 |
Why?
|
Health Behavior | 7 | 2022 | 2636 | 0.700 |
Why?
|
Cardiovascular Diseases | 14 | 2023 | 15165 | 0.690 |
Why?
|
Abdominal Fat | 1 | 2021 | 223 | 0.690 |
Why?
|
Fructosamine | 1 | 2018 | 14 | 0.680 |
Why?
|
Receptors, LDL | 3 | 2019 | 475 | 0.680 |
Why?
|
Waist Circumference | 9 | 2021 | 917 | 0.670 |
Why?
|
Gestational Age | 18 | 2023 | 3493 | 0.650 |
Why?
|
Male | 135 | 2024 | 350118 | 0.650 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2018 | 42 | 0.640 |
Why?
|
Genetic Loci | 8 | 2020 | 2575 | 0.640 |
Why?
|
Cohort Studies | 45 | 2024 | 40561 | 0.640 |
Why?
|
Glucose | 14 | 2024 | 4397 | 0.630 |
Why?
|
Pregnancy Trimesters | 4 | 2019 | 192 | 0.630 |
Why?
|
Pregnancy Outcome | 12 | 2024 | 2795 | 0.630 |
Why?
|
Intra-Abdominal Fat | 3 | 2020 | 591 | 0.620 |
Why?
|
Feeding Behavior | 6 | 2022 | 3188 | 0.620 |
Why?
|
Mercury | 4 | 2022 | 285 | 0.600 |
Why?
|
Young Adult | 42 | 2024 | 56430 | 0.600 |
Why?
|
Adipose Tissue | 6 | 2015 | 3279 | 0.600 |
Why?
|
Metabolomics | 6 | 2020 | 1484 | 0.590 |
Why?
|
Hypotension | 1 | 2023 | 884 | 0.590 |
Why?
|
Postpartum Period | 6 | 2023 | 1086 | 0.590 |
Why?
|
Adolescent | 58 | 2024 | 85781 | 0.590 |
Why?
|
Diet | 10 | 2021 | 7939 | 0.580 |
Why?
|
Corticotropin-Releasing Hormone | 1 | 2018 | 369 | 0.580 |
Why?
|
Metabolome | 2 | 2021 | 895 | 0.580 |
Why?
|
Fasting | 10 | 2019 | 1593 | 0.580 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2017 | 147 | 0.580 |
Why?
|
Insulin-Like Growth Factor II | 5 | 2021 | 271 | 0.570 |
Why?
|
Genetic Variation | 14 | 2019 | 6544 | 0.570 |
Why?
|
Diabetes Mellitus | 10 | 2023 | 5751 | 0.560 |
Why?
|
Child Behavior | 2 | 2019 | 839 | 0.560 |
Why?
|
Risk Reduction Behavior | 4 | 2020 | 1125 | 0.560 |
Why?
|
Prediabetic State | 5 | 2021 | 499 | 0.560 |
Why?
|
Glycemic Index | 1 | 2018 | 395 | 0.550 |
Why?
|
Erythroblasts | 1 | 2016 | 150 | 0.550 |
Why?
|
Adipokines | 4 | 2017 | 319 | 0.540 |
Why?
|
Genomic Imprinting | 4 | 2021 | 328 | 0.540 |
Why?
|
Genetic Association Studies | 6 | 2021 | 2703 | 0.530 |
Why?
|
Maternal Exposure | 7 | 2021 | 961 | 0.520 |
Why?
|
Smoking | 10 | 2021 | 8987 | 0.510 |
Why?
|
Preventive Medicine | 1 | 2017 | 264 | 0.510 |
Why?
|
Risk Factors | 49 | 2024 | 72290 | 0.510 |
Why?
|
Exercise | 9 | 2022 | 5615 | 0.500 |
Why?
|
Maternal Nutritional Physiological Phenomena | 3 | 2021 | 378 | 0.500 |
Why?
|
Linear Models | 11 | 2023 | 5952 | 0.500 |
Why?
|
Oligonucleotide Array Sequence Analysis | 5 | 2019 | 3920 | 0.490 |
Why?
|
Hair | 4 | 2023 | 483 | 0.490 |
Why?
|
Parenting | 1 | 2020 | 679 | 0.490 |
Why?
|
Metabolic Diseases | 6 | 2021 | 658 | 0.480 |
Why?
|
Lipid Metabolism | 3 | 2020 | 1889 | 0.480 |
Why?
|
Inservice Training | 1 | 2017 | 392 | 0.480 |
Why?
|
Genetic Markers | 3 | 2023 | 2634 | 0.480 |
Why?
|
Ghrelin | 2 | 2017 | 266 | 0.470 |
Why?
|
Premature Birth | 6 | 2023 | 1721 | 0.460 |
Why?
|
Blood Glucose Self-Monitoring | 2 | 2019 | 434 | 0.440 |
Why?
|
Infant | 29 | 2024 | 35136 | 0.420 |
Why?
|
Health Promotion | 5 | 2022 | 2205 | 0.410 |
Why?
|
Quebec | 4 | 2017 | 134 | 0.400 |
Why?
|
Prenatal Care | 2 | 2018 | 1092 | 0.400 |
Why?
|
Hypersensitivity, Immediate | 3 | 2019 | 337 | 0.400 |
Why?
|
Caprylates | 4 | 2020 | 111 | 0.400 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 4 | 2017 | 424 | 0.390 |
Why?
|
Body Composition | 5 | 2023 | 2401 | 0.390 |
Why?
|
Goals | 1 | 2016 | 706 | 0.390 |
Why?
|
Puberty | 4 | 2024 | 490 | 0.390 |
Why?
|
Metformin | 2 | 2015 | 835 | 0.380 |
Why?
|
Longitudinal Studies | 17 | 2024 | 13989 | 0.380 |
Why?
|
Education, Medical, Continuing | 1 | 2016 | 840 | 0.380 |
Why?
|
Counseling | 2 | 2016 | 1523 | 0.380 |
Why?
|
Cognition | 9 | 2023 | 6770 | 0.370 |
Why?
|
Quantitative Trait Loci | 5 | 2016 | 2019 | 0.360 |
Why?
|
Micronutrients | 2 | 2023 | 375 | 0.360 |
Why?
|
Hydrocortisone | 4 | 2023 | 1826 | 0.360 |
Why?
|
Food Preferences | 3 | 2023 | 399 | 0.360 |
Why?
|
Metals | 3 | 2023 | 719 | 0.350 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2012 | 392 | 0.350 |
Why?
|
Arsenic | 2 | 2024 | 328 | 0.350 |
Why?
|
Hunger | 1 | 2011 | 198 | 0.350 |
Why?
|
C-Peptide | 5 | 2018 | 419 | 0.340 |
Why?
|
MicroRNAs | 6 | 2022 | 3752 | 0.340 |
Why?
|
Breast Feeding | 4 | 2022 | 1338 | 0.340 |
Why?
|
Vitamin D Deficiency | 2 | 2016 | 1343 | 0.330 |
Why?
|
Promoter Regions, Genetic | 2 | 2018 | 5867 | 0.330 |
Why?
|
Massachusetts | 16 | 2022 | 8663 | 0.330 |
Why?
|
Energy Metabolism | 2 | 2019 | 2899 | 0.330 |
Why?
|
Pituitary-Adrenal System | 2 | 2022 | 553 | 0.320 |
Why?
|
Hypoglycemia | 1 | 2015 | 861 | 0.320 |
Why?
|
Mendelian Randomization Analysis | 6 | 2024 | 967 | 0.310 |
Why?
|
Interleukin-18 | 1 | 2009 | 249 | 0.310 |
Why?
|
Menarche | 2 | 2021 | 516 | 0.310 |
Why?
|
Sequence Analysis, DNA | 1 | 2019 | 4803 | 0.310 |
Why?
|
Sexual Maturation | 2 | 2019 | 265 | 0.300 |
Why?
|
Hypothalamo-Hypophyseal System | 2 | 2022 | 703 | 0.300 |
Why?
|
Asthma | 7 | 2023 | 6011 | 0.300 |
Why?
|
Residence Characteristics | 4 | 2022 | 2050 | 0.300 |
Why?
|
Blood Pressure | 8 | 2023 | 8554 | 0.300 |
Why?
|
Nasal Mucosa | 2 | 2021 | 373 | 0.300 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3597 | 0.290 |
Why?
|
Depression | 5 | 2023 | 7766 | 0.290 |
Why?
|
Hypoglycemic Agents | 4 | 2018 | 2872 | 0.280 |
Why?
|
Prenatal Diagnosis | 2 | 2021 | 1236 | 0.280 |
Why?
|
Gene Expression Regulation | 7 | 2021 | 12072 | 0.280 |
Why?
|
Menopause | 3 | 2022 | 1626 | 0.270 |
Why?
|
Infertility | 2 | 2024 | 655 | 0.270 |
Why?
|
Carbohydrate Metabolism | 3 | 2020 | 264 | 0.270 |
Why?
|
Bayes Theorem | 6 | 2023 | 2309 | 0.270 |
Why?
|
Inflammation | 4 | 2023 | 10638 | 0.270 |
Why?
|
Endocrine Disruptors | 2 | 2019 | 237 | 0.270 |
Why?
|
Delivery, Obstetric | 3 | 2021 | 906 | 0.260 |
Why?
|
Cross-Sectional Studies | 17 | 2024 | 25043 | 0.260 |
Why?
|
Maternal Age | 5 | 2019 | 802 | 0.260 |
Why?
|
Lipoprotein Lipase | 2 | 2017 | 126 | 0.260 |
Why?
|
Body Height | 5 | 2024 | 1577 | 0.260 |
Why?
|
Canada | 3 | 2021 | 2065 | 0.260 |
Why?
|
Metabolism | 2 | 2018 | 196 | 0.250 |
Why?
|
Chronic Disease | 2 | 2017 | 9146 | 0.250 |
Why?
|
Lipids | 5 | 2024 | 3305 | 0.250 |
Why?
|
Heart | 3 | 2024 | 4467 | 0.250 |
Why?
|
Sleep | 2 | 2022 | 4623 | 0.250 |
Why?
|
Electronic Health Records | 2 | 2012 | 4468 | 0.240 |
Why?
|
Triglycerides | 6 | 2018 | 2454 | 0.240 |
Why?
|
Alkanesulfonates | 1 | 2023 | 15 | 0.240 |
Why?
|
Infant, Low Birth Weight | 3 | 2018 | 850 | 0.230 |
Why?
|
Follow-Up Studies | 13 | 2021 | 39050 | 0.230 |
Why?
|
Glucocorticoids | 2 | 2023 | 2107 | 0.230 |
Why?
|
Insulin-Like Growth Factor I | 5 | 2017 | 2015 | 0.230 |
Why?
|
Health Personnel | 1 | 2017 | 3218 | 0.230 |
Why?
|
Physician-Patient Relations | 1 | 2016 | 3229 | 0.220 |
Why?
|
Executive Function | 3 | 2021 | 1364 | 0.220 |
Why?
|
Coronary Artery Disease | 4 | 2020 | 6487 | 0.220 |
Why?
|
Birth Order | 1 | 2023 | 95 | 0.220 |
Why?
|
Anthropometry | 5 | 2022 | 1350 | 0.220 |
Why?
|
Risk Assessment | 8 | 2020 | 23338 | 0.220 |
Why?
|
Principal Component Analysis | 2 | 2019 | 940 | 0.220 |
Why?
|
Hormones | 2 | 2017 | 889 | 0.220 |
Why?
|
Body Size | 4 | 2022 | 461 | 0.210 |
Why?
|
United States | 23 | 2024 | 69872 | 0.210 |
Why?
|
Blood Cells | 2 | 2022 | 309 | 0.210 |
Why?
|
Middle Aged | 36 | 2024 | 213383 | 0.210 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2016 | 3923 | 0.200 |
Why?
|
Health Status | 5 | 2022 | 4034 | 0.200 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2022 | 281 | 0.200 |
Why?
|
Attitude to Health | 2 | 2015 | 2052 | 0.200 |
Why?
|
Multivariate Analysis | 5 | 2021 | 12245 | 0.190 |
Why?
|
Models, Genetic | 3 | 2021 | 3494 | 0.190 |
Why?
|
Menopause, Premature | 1 | 2022 | 132 | 0.190 |
Why?
|
Trace Elements | 1 | 2022 | 198 | 0.190 |
Why?
|
Methylmercury Compounds | 1 | 2021 | 96 | 0.190 |
Why?
|
Clinical Competence | 1 | 2016 | 4687 | 0.190 |
Why?
|
Incidence | 10 | 2019 | 20947 | 0.190 |
Why?
|
Anti-Mullerian Hormone | 1 | 2023 | 402 | 0.190 |
Why?
|
Metals, Heavy | 1 | 2021 | 139 | 0.180 |
Why?
|
Trophoblasts | 1 | 2021 | 215 | 0.180 |
Why?
|
Food Contamination | 1 | 2021 | 188 | 0.180 |
Why?
|
Lead | 3 | 2023 | 852 | 0.180 |
Why?
|
Selenium | 1 | 2022 | 405 | 0.180 |
Why?
|
KCNQ1 Potassium Channel | 1 | 2019 | 104 | 0.180 |
Why?
|
Sphingolipids | 1 | 2021 | 159 | 0.180 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2024 | 370 | 0.180 |
Why?
|
Case-Control Studies | 11 | 2022 | 21746 | 0.170 |
Why?
|
Environmental Illness | 1 | 2019 | 34 | 0.170 |
Why?
|
Environment Design | 1 | 2021 | 178 | 0.170 |
Why?
|
Paternal Exposure | 1 | 2019 | 89 | 0.170 |
Why?
|
Respiratory Sounds | 2 | 2021 | 696 | 0.170 |
Why?
|
Weight Loss | 3 | 2019 | 2622 | 0.170 |
Why?
|
Crown-Rump Length | 1 | 2018 | 32 | 0.170 |
Why?
|
Socioeconomic Factors | 4 | 2021 | 7785 | 0.160 |
Why?
|
Parity | 4 | 2023 | 929 | 0.160 |
Why?
|
Satiation | 1 | 2019 | 80 | 0.160 |
Why?
|
Diet, Sodium-Restricted | 1 | 2020 | 287 | 0.160 |
Why?
|
Delivery of Health Care | 1 | 2017 | 5319 | 0.160 |
Why?
|
Sex Factors | 6 | 2022 | 10397 | 0.160 |
Why?
|
Europe | 7 | 2020 | 3339 | 0.160 |
Why?
|
Sickle Cell Trait | 1 | 2019 | 81 | 0.160 |
Why?
|
Appetite Regulation | 1 | 2019 | 88 | 0.160 |
Why?
|
Quantitative Trait, Heritable | 1 | 2021 | 544 | 0.160 |
Why?
|
Cesarean Section | 3 | 2024 | 1365 | 0.160 |
Why?
|
RecQ Helicases | 1 | 2018 | 54 | 0.160 |
Why?
|
Infant Formula | 1 | 2019 | 199 | 0.160 |
Why?
|
Ibuprofen | 1 | 2019 | 236 | 0.160 |
Why?
|
Anxiety | 3 | 2022 | 4297 | 0.160 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2019 | 265 | 0.160 |
Why?
|
Likelihood Functions | 1 | 2021 | 1005 | 0.150 |
Why?
|
Intelligence Tests | 1 | 2019 | 505 | 0.150 |
Why?
|
Placentation | 1 | 2018 | 82 | 0.150 |
Why?
|
DNA-Binding Proteins | 4 | 2019 | 9648 | 0.150 |
Why?
|
Environmental Exposure | 4 | 2021 | 4234 | 0.150 |
Why?
|
Consensus | 3 | 2023 | 2959 | 0.150 |
Why?
|
Anti-Bacterial Agents | 1 | 2016 | 7181 | 0.150 |
Why?
|
Manganese | 1 | 2020 | 408 | 0.150 |
Why?
|
Term Birth | 1 | 2018 | 135 | 0.150 |
Why?
|
Age Factors | 8 | 2022 | 18370 | 0.150 |
Why?
|
Gastric Inhibitory Polypeptide | 1 | 2017 | 59 | 0.150 |
Why?
|
Phospholipids | 1 | 2021 | 784 | 0.150 |
Why?
|
Gene Expression Profiling | 6 | 2024 | 9438 | 0.150 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2018 | 188 | 0.150 |
Why?
|
Thinness | 1 | 2020 | 480 | 0.150 |
Why?
|
Genome, Human | 4 | 2019 | 4420 | 0.140 |
Why?
|
Patient Education as Topic | 1 | 2007 | 2278 | 0.140 |
Why?
|
Growth Disorders | 1 | 2021 | 645 | 0.140 |
Why?
|
Electronic Mail | 1 | 2018 | 213 | 0.140 |
Why?
|
Intelligence | 1 | 2022 | 920 | 0.140 |
Why?
|
Policy Making | 1 | 2020 | 554 | 0.140 |
Why?
|
Coronary Disease | 3 | 2012 | 6077 | 0.140 |
Why?
|
Food Supply | 1 | 2022 | 524 | 0.140 |
Why?
|
Primary Health Care | 2 | 2009 | 4558 | 0.140 |
Why?
|
Adolescent Development | 1 | 2019 | 278 | 0.140 |
Why?
|
Peripheral Vascular Diseases | 1 | 2019 | 550 | 0.140 |
Why?
|
Behavior Therapy | 1 | 2022 | 865 | 0.140 |
Why?
|
Television | 1 | 2018 | 409 | 0.130 |
Why?
|
Erythrocytes | 3 | 2021 | 2455 | 0.130 |
Why?
|
Fetus | 3 | 2019 | 1880 | 0.130 |
Why?
|
Cholesterol | 3 | 2019 | 2917 | 0.130 |
Why?
|
Cardiomegaly | 1 | 2018 | 620 | 0.130 |
Why?
|
Postprandial Period | 1 | 2017 | 292 | 0.130 |
Why?
|
Social Responsibility | 1 | 2018 | 389 | 0.130 |
Why?
|
Peptide Hormones | 1 | 2016 | 134 | 0.130 |
Why?
|
Acetaminophen | 1 | 2019 | 545 | 0.130 |
Why?
|
Cluster Analysis | 2 | 2020 | 2715 | 0.130 |
Why?
|
Preventive Health Services | 1 | 2020 | 575 | 0.130 |
Why?
|
Immunoglobulin E | 2 | 2019 | 1463 | 0.130 |
Why?
|
Gene Regulatory Networks | 2 | 2021 | 1708 | 0.130 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2017 | 402 | 0.130 |
Why?
|
Phenotype | 9 | 2024 | 16365 | 0.130 |
Why?
|
Boston | 5 | 2021 | 9313 | 0.130 |
Why?
|
Diet, Mediterranean | 1 | 2022 | 700 | 0.130 |
Why?
|
Environment | 1 | 2021 | 1124 | 0.130 |
Why?
|
Apolipoprotein B-100 | 1 | 2015 | 148 | 0.130 |
Why?
|
Time Factors | 5 | 2022 | 40075 | 0.130 |
Why?
|
Public Health | 3 | 2024 | 2603 | 0.130 |
Why?
|
Age of Onset | 1 | 2022 | 3271 | 0.130 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2017 | 340 | 0.130 |
Why?
|
Evidence-Based Medicine | 3 | 2023 | 3610 | 0.120 |
Why?
|
Granulocytes | 1 | 2016 | 548 | 0.120 |
Why?
|
Causality | 1 | 2021 | 1275 | 0.120 |
Why?
|
Child Behavior Disorders | 1 | 2019 | 807 | 0.120 |
Why?
|
Organ Specificity | 2 | 2019 | 2008 | 0.120 |
Why?
|
Area Under Curve | 1 | 2018 | 1654 | 0.120 |
Why?
|
Subcutaneous Fat | 2 | 2015 | 391 | 0.120 |
Why?
|
Hypercholesterolemia | 1 | 2021 | 1151 | 0.120 |
Why?
|
Calcium Channels, L-Type | 1 | 2015 | 240 | 0.120 |
Why?
|
Folic Acid | 4 | 2023 | 1300 | 0.120 |
Why?
|
Motor Activity | 2 | 2016 | 2714 | 0.120 |
Why?
|
Health Occupations | 1 | 2015 | 224 | 0.120 |
Why?
|
Endocrinology | 1 | 2020 | 443 | 0.120 |
Why?
|
Zinc | 2 | 2024 | 684 | 0.120 |
Why?
|
Community-Institutional Relations | 1 | 2015 | 204 | 0.120 |
Why?
|
Pregnancy Trimester, Third | 1 | 2016 | 571 | 0.110 |
Why?
|
Odds Ratio | 7 | 2022 | 9849 | 0.110 |
Why?
|
Professional Competence | 1 | 2017 | 447 | 0.110 |
Why?
|
Body Fat Distribution | 1 | 2015 | 244 | 0.110 |
Why?
|
Receptors, Gastrointestinal Hormone | 2 | 2010 | 38 | 0.110 |
Why?
|
Regression Analysis | 2 | 2021 | 6459 | 0.110 |
Why?
|
Lipodystrophy | 1 | 2014 | 147 | 0.110 |
Why?
|
Aged | 18 | 2021 | 163280 | 0.110 |
Why?
|
Gene Expression Regulation, Developmental | 4 | 2018 | 3617 | 0.110 |
Why?
|
Dietary Fats | 1 | 2021 | 2017 | 0.110 |
Why?
|
Hypertension | 3 | 2021 | 8480 | 0.110 |
Why?
|
Signal Transduction | 2 | 2015 | 23403 | 0.110 |
Why?
|
Infant, Premature | 2 | 2020 | 2044 | 0.110 |
Why?
|
Leukocyte Count | 1 | 2016 | 1588 | 0.110 |
Why?
|
Repressor Proteins | 3 | 2021 | 3023 | 0.110 |
Why?
|
Adult Children | 1 | 2013 | 100 | 0.100 |
Why?
|
Feasibility Studies | 2 | 2020 | 5078 | 0.100 |
Why?
|
Dietary Proteins | 1 | 2017 | 963 | 0.100 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2019 | 6038 | 0.100 |
Why?
|
Research Design | 4 | 2020 | 5987 | 0.100 |
Why?
|
Food Hypersensitivity | 1 | 2019 | 622 | 0.100 |
Why?
|
Focus Groups | 1 | 2016 | 1321 | 0.100 |
Why?
|
Fetal Hemoglobin | 1 | 2014 | 341 | 0.100 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2013 | 311 | 0.100 |
Why?
|
Receptor, IGF Type 1 | 1 | 2014 | 390 | 0.100 |
Why?
|
Practice Guidelines as Topic | 3 | 2020 | 7279 | 0.100 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2013 | 563 | 0.100 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2017 | 1114 | 0.100 |
Why?
|
Societies, Medical | 3 | 2020 | 3743 | 0.100 |
Why?
|
Developmental Disabilities | 1 | 2019 | 1456 | 0.100 |
Why?
|
ROC Curve | 1 | 2018 | 3527 | 0.100 |
Why?
|
Morbidity | 1 | 2016 | 1769 | 0.090 |
Why?
|
Prevalence | 7 | 2022 | 15226 | 0.090 |
Why?
|
Clinical Trials as Topic | 1 | 2006 | 7913 | 0.090 |
Why?
|
Pilot Projects | 2 | 2018 | 8324 | 0.090 |
Why?
|
Blood Specimen Collection | 1 | 2012 | 246 | 0.090 |
Why?
|
Androgens | 1 | 2018 | 1281 | 0.090 |
Why?
|
Social Class | 1 | 2019 | 1999 | 0.090 |
Why?
|
Pregnancy in Diabetics | 1 | 2011 | 179 | 0.090 |
Why?
|
Computer Simulation | 2 | 2021 | 6196 | 0.090 |
Why?
|
Population Surveillance | 1 | 2021 | 2616 | 0.090 |
Why?
|
Postnatal Care | 1 | 2012 | 236 | 0.090 |
Why?
|
Social Support | 1 | 2019 | 2118 | 0.090 |
Why?
|
Mental Health | 2 | 2022 | 3019 | 0.090 |
Why?
|
Carnitine O-Palmitoyltransferase | 2 | 2021 | 86 | 0.090 |
Why?
|
Aging | 3 | 2024 | 8664 | 0.090 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2013 | 584 | 0.090 |
Why?
|
Waist-Hip Ratio | 3 | 2015 | 517 | 0.080 |
Why?
|
Parents | 2 | 2019 | 3407 | 0.080 |
Why?
|
Cation Transport Proteins | 1 | 2011 | 327 | 0.080 |
Why?
|
Menstrual Cycle | 2 | 2022 | 551 | 0.080 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2022 | 2208 | 0.080 |
Why?
|
Health Education | 1 | 2015 | 1056 | 0.080 |
Why?
|
Educational Status | 3 | 2022 | 2540 | 0.080 |
Why?
|
DNA | 2 | 2020 | 7301 | 0.080 |
Why?
|
Molecular Weight | 1 | 2010 | 2255 | 0.080 |
Why?
|
Atherosclerosis | 2 | 2015 | 3445 | 0.080 |
Why?
|
Qualitative Research | 1 | 2016 | 2682 | 0.080 |
Why?
|
Fruit | 1 | 2013 | 1142 | 0.080 |
Why?
|
Vegetables | 1 | 2013 | 1182 | 0.080 |
Why?
|
Predictive Value of Tests | 3 | 2014 | 15076 | 0.080 |
Why?
|
Air Pollution | 1 | 2021 | 2286 | 0.070 |
Why?
|
Physicians, Family | 1 | 2009 | 345 | 0.070 |
Why?
|
Self Report | 3 | 2022 | 3558 | 0.070 |
Why?
|
Monocytes | 1 | 2016 | 2596 | 0.070 |
Why?
|
Antidepressive Agents | 1 | 2019 | 2838 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2020 | 9959 | 0.070 |
Why?
|
Nerve Tissue Proteins | 1 | 2019 | 4462 | 0.070 |
Why?
|
Cell Lineage | 1 | 2015 | 2504 | 0.070 |
Why?
|
Homeostasis | 2 | 2019 | 3340 | 0.070 |
Why?
|
Insulin-Secreting Cells | 1 | 2013 | 891 | 0.070 |
Why?
|
Algorithms | 2 | 2021 | 13881 | 0.070 |
Why?
|
Transcription Factors | 4 | 2019 | 12208 | 0.070 |
Why?
|
Workplace | 2 | 2023 | 836 | 0.070 |
Why?
|
Cholesterol, LDL | 1 | 2015 | 2356 | 0.070 |
Why?
|
North America | 2 | 2019 | 1249 | 0.060 |
Why?
|
Vitamin D | 2 | 2016 | 3223 | 0.060 |
Why?
|
Alcohol Drinking | 1 | 2017 | 3966 | 0.060 |
Why?
|
Vitamins | 2 | 2024 | 1622 | 0.060 |
Why?
|
Netherlands | 2 | 2021 | 2170 | 0.060 |
Why?
|
Retrospective Studies | 7 | 2024 | 77449 | 0.060 |
Why?
|
Reproducibility of Results | 2 | 2021 | 19905 | 0.060 |
Why?
|
Statistics as Topic | 1 | 2011 | 2373 | 0.060 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2019 | 3047 | 0.060 |
Why?
|
Prenatal Nutritional Physiological Phenomena | 2 | 2017 | 159 | 0.060 |
Why?
|
Health Services | 1 | 2009 | 758 | 0.060 |
Why?
|
Transcription Factor 7-Like 2 Protein | 2 | 2018 | 154 | 0.060 |
Why?
|
Proto-Oncogene Proteins | 1 | 2016 | 4554 | 0.060 |
Why?
|
Colon | 2 | 1983 | 1772 | 0.060 |
Why?
|
Alleles | 4 | 2018 | 6933 | 0.060 |
Why?
|
Exercise Therapy | 1 | 2011 | 906 | 0.060 |
Why?
|
Sex Characteristics | 3 | 2022 | 2585 | 0.060 |
Why?
|
Autoimmune Diseases | 1 | 2015 | 2133 | 0.060 |
Why?
|
Linkage Disequilibrium | 1 | 2008 | 1997 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3870 | 0.060 |
Why?
|
Health Policy | 1 | 2015 | 2661 | 0.050 |
Why?
|
Alzheimer Disease | 1 | 2023 | 8037 | 0.050 |
Why?
|
Communication | 1 | 2016 | 3749 | 0.050 |
Why?
|
Plants, Toxic | 1 | 1982 | 76 | 0.050 |
Why?
|
Quality of Life | 2 | 2020 | 12804 | 0.050 |
Why?
|
RNA, Messenger | 5 | 2016 | 13033 | 0.050 |
Why?
|
Cholesterol, HDL | 3 | 2013 | 1814 | 0.050 |
Why?
|
Gene Expression | 3 | 2022 | 7799 | 0.050 |
Why?
|
Metabolic Networks and Pathways | 2 | 2019 | 783 | 0.050 |
Why?
|
Cadmium | 1 | 2022 | 212 | 0.050 |
Why?
|
Models, Structural | 1 | 2021 | 361 | 0.050 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2021 | 141 | 0.050 |
Why?
|
Software | 1 | 2015 | 4443 | 0.050 |
Why?
|
Mediator Complex | 1 | 2021 | 109 | 0.050 |
Why?
|
Choline | 1 | 2022 | 493 | 0.050 |
Why?
|
Carbohydrates | 1 | 2023 | 394 | 0.050 |
Why?
|
Pedigree | 1 | 2008 | 4644 | 0.050 |
Why?
|
Guanine | 1 | 2022 | 274 | 0.050 |
Why?
|
Cytosine | 1 | 2022 | 216 | 0.050 |
Why?
|
Skinfold Thickness | 1 | 2020 | 162 | 0.050 |
Why?
|
Smoke | 1 | 1982 | 227 | 0.050 |
Why?
|
Mass Spectrometry | 2 | 2018 | 2203 | 0.050 |
Why?
|
European Union | 1 | 2021 | 158 | 0.050 |
Why?
|
Stochastic Processes | 1 | 2021 | 344 | 0.050 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2024 | 780 | 0.050 |
Why?
|
Carbon | 1 | 2024 | 687 | 0.050 |
Why?
|
Mexico | 1 | 2022 | 690 | 0.050 |
Why?
|
Eating | 1 | 2007 | 1536 | 0.040 |
Why?
|
Republic of Belarus | 1 | 2019 | 38 | 0.040 |
Why?
|
Scavenger Receptors, Class B | 1 | 2019 | 81 | 0.040 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2022 | 370 | 0.040 |
Why?
|
Sweetening Agents | 1 | 2022 | 296 | 0.040 |
Why?
|
Models, Biological | 2 | 2015 | 9583 | 0.040 |
Why?
|
Patient Care Team | 1 | 2011 | 2531 | 0.040 |
Why?
|
Personnel, Hospital | 1 | 2022 | 283 | 0.040 |
Why?
|
China | 2 | 2017 | 2248 | 0.040 |
Why?
|
Milk | 1 | 2022 | 450 | 0.040 |
Why?
|
Oceania | 1 | 2018 | 17 | 0.040 |
Why?
|
Perception | 2 | 2019 | 1198 | 0.040 |
Why?
|
Financial Management | 1 | 2020 | 160 | 0.040 |
Why?
|
Kv1.3 Potassium Channel | 1 | 2018 | 7 | 0.040 |
Why?
|
Policy | 1 | 2022 | 508 | 0.040 |
Why?
|
Chromosome Mapping | 2 | 2018 | 4740 | 0.040 |
Why?
|
Hemoglobin, Sickle | 1 | 2019 | 122 | 0.040 |
Why?
|
Proportional Hazards Models | 2 | 2014 | 12354 | 0.040 |
Why?
|
Phosphates | 1 | 2022 | 786 | 0.040 |
Why?
|
GPI-Linked Proteins | 1 | 2019 | 434 | 0.040 |
Why?
|
England | 1 | 2019 | 522 | 0.040 |
Why?
|
Fenofibrate | 1 | 2018 | 88 | 0.040 |
Why?
|
Puberty, Precocious | 1 | 2019 | 156 | 0.040 |
Why?
|
Gene Frequency | 2 | 2016 | 3588 | 0.040 |
Why?
|
Genetic Heterogeneity | 1 | 2021 | 733 | 0.040 |
Why?
|
Puerperal Disorders | 1 | 2020 | 275 | 0.040 |
Why?
|
Cytochrome P-450 CYP3A | 1 | 2018 | 115 | 0.040 |
Why?
|
Expert Testimony | 1 | 2020 | 356 | 0.040 |
Why?
|
HMGA2 Protein | 1 | 2018 | 123 | 0.040 |
Why?
|
Seasons | 1 | 2023 | 1493 | 0.040 |
Why?
|
Mitosis | 1 | 1983 | 1208 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2018 | 318 | 0.040 |
Why?
|
Receptor, Melatonin, MT2 | 1 | 2018 | 77 | 0.040 |
Why?
|
Aryldialkylphosphatase | 1 | 2017 | 63 | 0.040 |
Why?
|
Health Plan Implementation | 1 | 2020 | 352 | 0.040 |
Why?
|
Students | 1 | 2007 | 1654 | 0.040 |
Why?
|
Congresses as Topic | 1 | 2022 | 764 | 0.040 |
Why?
|
Beverages | 1 | 2022 | 820 | 0.040 |
Why?
|
Seafood | 1 | 2020 | 384 | 0.040 |
Why?
|
Environmental Pollution | 1 | 2018 | 118 | 0.040 |
Why?
|
Norway | 1 | 2017 | 448 | 0.040 |
Why?
|
Genetic Testing | 1 | 2009 | 3444 | 0.040 |
Why?
|
DNA, Mitochondrial | 1 | 2021 | 817 | 0.040 |
Why?
|
Cattle | 1 | 2022 | 3922 | 0.030 |
Why?
|
Patient Compliance | 1 | 2007 | 2684 | 0.030 |
Why?
|
Vital Capacity | 1 | 2019 | 925 | 0.030 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2019 | 365 | 0.030 |
Why?
|
Internationality | 1 | 2022 | 1003 | 0.030 |
Why?
|
Histone Deacetylases | 1 | 2021 | 728 | 0.030 |
Why?
|
Kidney | 2 | 2022 | 7186 | 0.030 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2022 | 1205 | 0.030 |
Why?
|
Probability | 1 | 2021 | 2505 | 0.030 |
Why?
|
Arteries | 1 | 2021 | 1119 | 0.030 |
Why?
|
Australia | 1 | 2019 | 1170 | 0.030 |
Why?
|
History, 21st Century | 1 | 2022 | 1534 | 0.030 |
Why?
|
Animals | 7 | 2022 | 168757 | 0.030 |
Why?
|
Telomere | 1 | 2021 | 910 | 0.030 |
Why?
|
Risk | 2 | 2018 | 9687 | 0.030 |
Why?
|
Prognosis | 3 | 2021 | 29063 | 0.030 |
Why?
|
Hypertriglyceridemia | 1 | 2018 | 293 | 0.030 |
Why?
|
Glucose-6-Phosphatase | 1 | 2015 | 73 | 0.030 |
Why?
|
Longevity | 1 | 2023 | 1070 | 0.030 |
Why?
|
Malnutrition | 1 | 2022 | 625 | 0.030 |
Why?
|
Microvessels | 1 | 2019 | 544 | 0.030 |
Why?
|
Meta-Analysis as Topic | 2 | 2010 | 1344 | 0.030 |
Why?
|
Growth | 1 | 2017 | 376 | 0.030 |
Why?
|
Intestinal Mucosa | 2 | 1983 | 3036 | 0.030 |
Why?
|
Nutrition Surveys | 1 | 2021 | 1660 | 0.030 |
Why?
|
Chromatography, Liquid | 1 | 2018 | 976 | 0.030 |
Why?
|
Cell Division | 1 | 1982 | 4568 | 0.030 |
Why?
|
Forced Expiratory Volume | 1 | 2019 | 1743 | 0.030 |
Why?
|
Molecular Sequence Annotation | 1 | 2016 | 528 | 0.030 |
Why?
|
Collagen | 1 | 1982 | 2689 | 0.030 |
Why?
|
Introns | 1 | 2016 | 991 | 0.030 |
Why?
|
Occupational Diseases | 1 | 2022 | 1471 | 0.030 |
Why?
|
Adaptation, Physiological | 1 | 2020 | 1312 | 0.030 |
Why?
|
Logistic Models | 1 | 2008 | 13408 | 0.030 |
Why?
|
DNA Copy Number Variations | 1 | 2021 | 1941 | 0.030 |
Why?
|
Ankle Brachial Index | 1 | 2013 | 154 | 0.030 |
Why?
|
Biomedical Research | 2 | 2020 | 3309 | 0.030 |
Why?
|
Diagnostic Techniques, Endocrine | 1 | 2012 | 45 | 0.030 |
Why?
|
Mitotic Index | 2 | 1983 | 172 | 0.030 |
Why?
|
Adipogenesis | 1 | 2015 | 359 | 0.030 |
Why?
|
Somatomedins | 1 | 2012 | 192 | 0.030 |
Why?
|
Models, Organizational | 1 | 2015 | 574 | 0.030 |
Why?
|
Body Patterning | 1 | 2016 | 626 | 0.020 |
Why?
|
Aged, 80 and over | 4 | 2019 | 57776 | 0.020 |
Why?
|
Glycosylation | 1 | 2014 | 1126 | 0.020 |
Why?
|
Cleft Lip | 1 | 2016 | 478 | 0.020 |
Why?
|
Sulfonamides | 1 | 2020 | 1938 | 0.020 |
Why?
|
Tobacco Smoke Pollution | 1 | 2017 | 816 | 0.020 |
Why?
|
Preconception Care | 1 | 2011 | 134 | 0.020 |
Why?
|
Cleft Palate | 1 | 2016 | 560 | 0.020 |
Why?
|
Actins | 1 | 2018 | 2121 | 0.020 |
Why?
|
Patient-Centered Care | 1 | 2020 | 1439 | 0.020 |
Why?
|
Aorta, Abdominal | 1 | 2013 | 646 | 0.020 |
Why?
|
Receptor, Insulin | 1 | 2014 | 846 | 0.020 |
Why?
|
Fatty Acid Desaturases | 1 | 2010 | 102 | 0.020 |
Why?
|
Islets of Langerhans | 1 | 2016 | 1352 | 0.020 |
Why?
|
TCF Transcription Factors | 1 | 2010 | 140 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15540 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2016 | 1341 | 0.020 |
Why?
|
Program Development | 1 | 2016 | 1316 | 0.020 |
Why?
|
Particulate Matter | 1 | 2021 | 2530 | 0.020 |
Why?
|
Models, Animal | 1 | 2016 | 2171 | 0.020 |
Why?
|
Acute Disease | 1 | 2020 | 7149 | 0.020 |
Why?
|
Proteins | 2 | 2018 | 6103 | 0.020 |
Why?
|
Incretins | 1 | 2010 | 88 | 0.020 |
Why?
|
Mitochondria | 1 | 2021 | 3520 | 0.020 |
Why?
|
Diet Surveys | 1 | 2012 | 1173 | 0.020 |
Why?
|
Adipocytes | 1 | 2015 | 1184 | 0.020 |
Why?
|
Trans-Activators | 1 | 2018 | 2924 | 0.020 |
Why?
|
Neovascularization, Physiologic | 1 | 2015 | 1351 | 0.020 |
Why?
|
Denmark | 1 | 2010 | 738 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2018 | 2915 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2021 | 5021 | 0.020 |
Why?
|
Comorbidity | 1 | 2022 | 10388 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 2016 | 1903 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2018 | 2916 | 0.020 |
Why?
|
Professional Practice | 1 | 2009 | 326 | 0.020 |
Why?
|
Privacy | 1 | 2009 | 239 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2019 | 6993 | 0.020 |
Why?
|
Infant, Newborn, Diseases | 1 | 2011 | 582 | 0.020 |
Why?
|
Echocardiography | 1 | 2018 | 5102 | 0.020 |
Why?
|
Heart Diseases | 1 | 2019 | 2788 | 0.020 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2020 | 3336 | 0.020 |
Why?
|
Pharmacogenetics | 1 | 2009 | 675 | 0.020 |
Why?
|
Diabetes Complications | 1 | 2012 | 1359 | 0.020 |
Why?
|
Antigens, CD | 1 | 2014 | 4026 | 0.010 |
Why?
|
Patients | 1 | 2009 | 900 | 0.010 |
Why?
|
Methods | 1 | 1983 | 1129 | 0.010 |
Why?
|
Program Evaluation | 1 | 2011 | 2488 | 0.010 |
Why?
|
Chromatography, Gas | 1 | 1982 | 156 | 0.010 |
Why?
|
Autoradiography | 1 | 1983 | 745 | 0.010 |
Why?
|
Medicine | 1 | 2009 | 946 | 0.010 |
Why?
|
Hemoglobin A | 1 | 1980 | 87 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2015 | 7722 | 0.010 |
Why?
|
Mathematics | 1 | 1982 | 728 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2010 | 2421 | 0.010 |
Why?
|
Proline | 1 | 1982 | 458 | 0.010 |
Why?
|
Glycosides | 1 | 1980 | 107 | 0.010 |
Why?
|
Data Collection | 1 | 2009 | 3341 | 0.010 |
Why?
|
Cytological Techniques | 1 | 1982 | 219 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2020 | 63114 | 0.010 |
Why?
|
Motivation | 1 | 2009 | 1971 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2010 | 2849 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2009 | 4328 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2011 | 5391 | 0.010 |
Why?
|
Mice | 2 | 1983 | 81183 | 0.010 |
Why?
|
Computational Biology | 1 | 2009 | 3521 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 1982 | 2126 | 0.010 |
Why?
|
Cell Cycle | 1 | 1983 | 2967 | 0.010 |
Why?
|
Databases, Factual | 1 | 2009 | 7729 | 0.010 |
Why?
|
Fibroblasts | 1 | 1982 | 4161 | 0.010 |
Why?
|
Peptides | 1 | 1980 | 4409 | 0.000 |
Why?
|